Thangaratinam and colleagues aimed to shed light on the potential predictive value of using pulse oximetry to screen for significant cyanotic congenital heart disease (CHD) in newborn infants. One ...
MASI's SET pulse oximetry shows accurate, consistent readings in hospitalized newborns across all skin tones in the largest real-world study.
Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.
Masimo's NeoPODS study found its SET pulse oximetry technology delivered consistent accuracy in critically ill newborns across all skin tones, addressing longstanding concerns over racial bias in ...
Masimo’s NeoPODS study in critically ill newborns found its SET pulse oximetry technology delivered consistent accuracy across all skin tones, with less than 1% bias. The findings address longstanding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results